CSNK2A2 and cancer: Interestingly, PIP4K2C expression has been associated with outcomes in Acute Myeloid Leukemia (AML) (Lima et al., 2019), while CSNK2A2 has been associated significantly with prognoses of 14 different cancer types (Strum, Gyenis & Litchfield, 2022).